WASHINGTON — Senior administration officials are promising that Friday afternoon, President Trump will roll out “the most comprehensive plan to tackle prescription drug affordability of any president.”

But ahead of his 2 p.m. remarks, the White House is keeping the actual plans under wraps — only hinting at the kinds of new policies that might come out in a “blueprint,” to be released alongside the speech and entitled “American Patients First.” In a late Thursday call with reporters, two senior administration officials largely deflected questions about exactly what’s to come in that blueprint, or in a separate “request for information” — an early regulatory outline of proposals — that will also accompany the remarks.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy